Cargando…

Effect of educative reminder telephone calls on human papillomavirus immunization rate: A randomized controlled trial

CONTEXT: Human papillomavirus coverage varies widely among women depending on their race, incomes, geographical location and education level. OBJECTIVE: To evaluate whether reminder educative phone calls increase human papillomavirus vaccination rates in adult women aged 18–45 with high-risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernard-Genest, Marie-Pier, Ruel-Laliberté, Jessica, Lapointe-Milot, Korine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010846/
https://www.ncbi.nlm.nih.gov/pubmed/33779417
http://dx.doi.org/10.1177/17455065211003821
_version_ 1783673139648004096
author Bernard-Genest, Marie-Pier
Ruel-Laliberté, Jessica
Lapointe-Milot, Korine
author_facet Bernard-Genest, Marie-Pier
Ruel-Laliberté, Jessica
Lapointe-Milot, Korine
author_sort Bernard-Genest, Marie-Pier
collection PubMed
description CONTEXT: Human papillomavirus coverage varies widely among women depending on their race, incomes, geographical location and education level. OBJECTIVE: To evaluate whether reminder educative phone calls increase human papillomavirus vaccination rates in adult women aged 18–45 with high-risk factors of cervical cancer. DESIGN: We conducted a single-blind randomized controlled trial in patients who consulted at a Canadian tertiary center in October 2019 during National Cervical Cancer Awareness Week. INTERVENTIONS: We randomized women to receive three standardized educative phone calls or standard care. MAIN OUTCOME MEASURE: We assessed the immunization rate at 6 months. RESULTS: A total of 130 patients were randomized of which 62 patients were randomized to the intervention. Eight patients (15.4%) got immunized at 6 months in the intervention group as compared to seven (11.7%) in the control group (p = 0.5645). The main barrier to vaccination reported by non-immunized patients at 6 months was the cost of vaccination (42.3%). CONCLUSION: Reminder educative phone calls did not increase human papillomavirus vaccination rates in adult women with risk factors of cervical cancer. ISRCTN registration number: ISRCTN58518971
format Online
Article
Text
id pubmed-8010846
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-80108462021-04-13 Effect of educative reminder telephone calls on human papillomavirus immunization rate: A randomized controlled trial Bernard-Genest, Marie-Pier Ruel-Laliberté, Jessica Lapointe-Milot, Korine Womens Health (Lond) Cervical Cancer CONTEXT: Human papillomavirus coverage varies widely among women depending on their race, incomes, geographical location and education level. OBJECTIVE: To evaluate whether reminder educative phone calls increase human papillomavirus vaccination rates in adult women aged 18–45 with high-risk factors of cervical cancer. DESIGN: We conducted a single-blind randomized controlled trial in patients who consulted at a Canadian tertiary center in October 2019 during National Cervical Cancer Awareness Week. INTERVENTIONS: We randomized women to receive three standardized educative phone calls or standard care. MAIN OUTCOME MEASURE: We assessed the immunization rate at 6 months. RESULTS: A total of 130 patients were randomized of which 62 patients were randomized to the intervention. Eight patients (15.4%) got immunized at 6 months in the intervention group as compared to seven (11.7%) in the control group (p = 0.5645). The main barrier to vaccination reported by non-immunized patients at 6 months was the cost of vaccination (42.3%). CONCLUSION: Reminder educative phone calls did not increase human papillomavirus vaccination rates in adult women with risk factors of cervical cancer. ISRCTN registration number: ISRCTN58518971 SAGE Publications 2021-03-27 /pmc/articles/PMC8010846/ /pubmed/33779417 http://dx.doi.org/10.1177/17455065211003821 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Cervical Cancer
Bernard-Genest, Marie-Pier
Ruel-Laliberté, Jessica
Lapointe-Milot, Korine
Effect of educative reminder telephone calls on human papillomavirus immunization rate: A randomized controlled trial
title Effect of educative reminder telephone calls on human papillomavirus immunization rate: A randomized controlled trial
title_full Effect of educative reminder telephone calls on human papillomavirus immunization rate: A randomized controlled trial
title_fullStr Effect of educative reminder telephone calls on human papillomavirus immunization rate: A randomized controlled trial
title_full_unstemmed Effect of educative reminder telephone calls on human papillomavirus immunization rate: A randomized controlled trial
title_short Effect of educative reminder telephone calls on human papillomavirus immunization rate: A randomized controlled trial
title_sort effect of educative reminder telephone calls on human papillomavirus immunization rate: a randomized controlled trial
topic Cervical Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010846/
https://www.ncbi.nlm.nih.gov/pubmed/33779417
http://dx.doi.org/10.1177/17455065211003821
work_keys_str_mv AT bernardgenestmariepier effectofeducativeremindertelephonecallsonhumanpapillomavirusimmunizationratearandomizedcontrolledtrial
AT ruellalibertejessica effectofeducativeremindertelephonecallsonhumanpapillomavirusimmunizationratearandomizedcontrolledtrial
AT lapointemilotkorine effectofeducativeremindertelephonecallsonhumanpapillomavirusimmunizationratearandomizedcontrolledtrial